Differentiation and proliferation in mouse embryonal carcinoma cells

BioEssays

Volumn 14, Issue 11, 1992, Pages 769-775

  Sleigh, Merilyn J ^a  

^a CSIRO MOLECULAR AND HEALTH TECHNOLOGIES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; EMBRYONAL CARCINOMA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE RAS; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMAL; BASE SEQUENCE; CARCINOMA, EMBRYONAL; CELL DIFFERENTIATION; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, JUN; GENES, RAS; MICE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0026955973     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.950141109     Document Type: Review

References (48)

1. F9 teraiocarcinoma cells as a model for the differentiation of parietal and visceral endoderm in the mouse embryo
2. The induction of differentiation in teratocarcinoma cells by retinoic acid
3. Hormonal induction differentiation in teratocarcinoma stem cells
4. Virus expression as a probe of a regulatory events in early mouse embryogenesis
5. Gene expression and differentiation in F9 mouse embryonal carcinoma cells
6. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells
7. Ectopic expression of c‐jun leads to differentiation of P19 embryonal carcinoma cells
8. Elevation of AP‐1 activity during F9 cell differentiation is due to increased c‐jun transcription
9. Nuclear oncoproteins as transcription factors
10. Transcriptional regulation of the c‐jun gene by retinoic acid and E1A during differentiation of F9 cells
11. Cyclic AMP analogs and relinoic acid influence the expression of retinoic acid receptor α, β, and γ mRNAs in F9 teratocarcinoma cells
12. Identification of a retinoic acid responsive element in the retinoic acid receptor β gene
13. Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene
14. Studies on the relation of DNA synthesis to retinoic acid‐induced differentiation of F9 teratocarcinoma cells
15. Transcriptional control of c‐jun by retinoic acid
16. v‐Src and EJ Ras alleviate repression of c‐Jun by a cell‐specific inhibitor
17. The c‐Ha‐ras oncogene and a tumor promoter activate the polyma virus enhancer
18. Negative and positive regulation by transcription factor cAMP response elementbinding protein is modulated by phosphorylation
19. Cross‐coupling of Ap‐l and intracellular hormone receptors
20. The CREB family of transcription activators
21. Characterization of three KXR genes that mediate the action of 9‐cis retinoic acid
22. 3 signalling
23. Multiple cell type‐specific proteins differentially regulate target sequence recognition by the α retinoic acid receptor
24. Antagonism between retinoic acid receptors and Apl: implications for tumor promotion and inflammation
25. The late relinoic acid induction of laminin B1 gene transcription involves RAR binding to the responsive element
26. A retinoic acid‐responsive element is present in the 5' flanking region of the laminin B1 gene
27. 3 receptors
28. Retinoic acid receptor expression vector inhibits differentiation of F9 embryonal carcinoma cells
29. Activation of the polyomavirus enhancer by a murine activator protein 1 (AP‐1) homolog and two contiguous proteins
30. Negative and positive factors determine the activity of the polyoma virus enhancer α domain in undifferentiated and differentiated cell types
31. The SV40 TC‐II(kB) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non‐lymphoid cell lines
32. Pleiotrophic derepression of developmentally regulated cellular and viral genes by c‐myc proto‐oncogene products in undifferentiated embryonal carcinoma cells
33. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor
34. The E2F transcription factor is a cellular target for the RB protein
35. The interaction of RB with E2F coincides with an inhibition of the transcriplional activity of E2F
36. The retinoblastoma‐susceptibility gene product becomes phosphorylated in multiple staes during cell cycle entry and progression
37. A transcriptional tryst
38. Multicomponent differentiation regulated transcription factors in F9 embryonal carcinoma stem cells
39. Developmental control of a promoter‐specific factor that is also regulated by the E1A gene product
40. Leukemia inhibitory factor: a biological perspective
41. b enhansons exhibit different cell type specific and inducible protoenhancer activities, but the SV40 core sequence and the AP‐2 binding site have no enhanson properties
42. b class I major histocompatibility gene
43. A multiplicity of differentiation‐regulated ATF site‐binding activities in embryonal carcinoma cells with distinct sequence and promoter specificities
44. Negative regulation of the major histocompatibility complex class i promoter in embryonal carcinoma cells
45. Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor
46. Protein synthesis inhibitors prevent the induction of laminin B1, collagen IV(a). and other differentiation‐specific mRNAs by retinoic acid in F9 teratocarcinoma cells
47. Experssion of REX‐1 a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells